Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Orladeyo 150 mg hard capsules
DRUG
2 trials
Sponsors
Biocryst Pharmaceuticals Inc.
, Policlinico San Donato S.p.A.
Conditions
Acquired angioedema due to C1 inhibitor deficiency
Hereditary Angioedema (HAE)
Phase 2
AN OPEN LABEL, SINGLE ARM, EXPLORATIVE TRIAL TO EVALUATE EFFICACY AND SAFETY OF BEROTRALSTAT IN PREVENTING ANGIOEDEMA ATTACKS IN SUBJECTS WITH ACQUIRED ANGIOEDEMA DUE TO C1 INHIBITOR DEFICIENCY (AAE)
Not yet recruiting
CTIS2025-524747-13-00
Policlinico San Donato S.p.A.
Acquired angioedema due to C1 inhibitor deficiency
Target: 16
Updated: 2026-08-12
Phase 3
A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children with Hereditary Angioedema (HAE) Who Are 2 To < 12 Years of Age.
Active, not recruiting
CTIS2024-511257-22-00
Biocryst Pharmaceuticals Inc.
Hereditary Angioedema (HAE)
Start: 2022-10-13
Target: 19
Updated: 2025-09-29
Related Papers
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years
Annals of Allergy Asthma & Immunology
2025-07-25
3 citations